Cardiac troponin I release after transcatheter closure of the interatrial septum: A prospective study

Acta Cardiologica

Volumn 62, Issue 5, 2007, Pages 467-471

  Vydt, Tom ^a,b   Vermeersch, Paul ^a   Schwagten, Bruno ^a   Budts, Werner ^b  

^a AZ Middelheim ^*  (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Atrial septal defect; Patent foramen ovale; Percutaneous intervention; Troponin

Indexed keywords

TROPONIN T; TROPONIN T 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; WORLD HEALTH ORGANIZATION;

ADULT; AGED; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TROPONIN I;

EID: 35348828469     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.62.5.2023409     Document Type: Article

References (13)

1. Adams JE III, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993; 88: 101-6.
2. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342-9.
3. Cantor WJ, Newby LK, Christenson RH, Tuttle RH, Hasselblad V, Armstrong PW, Moliterno DJ, Califf RM, Topol EJ, Ohman EM. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002; 39: 1738-44.
4. Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart 2006; 92: 987-93.
5. Ricciardi MJ, Davidson CJ, Gubernikoff G, Beohar N, Eckman LJ, Parker MA, Bonow RO. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 2003; 145: 522-8.
6. Pees C, Haas NA, von der Beek J, Ewert P, Berger F, Lange PE. Cardiac troponin I is increased after interventional closure of atrial septal defects. Catheter Cardiovasc Interv 2003; 58: 124-9.
7. Tarnok A, Bocsi J, Osmancik P, Hausler HJ, Schneider P, Dahnert I. Cardiac troponin I release after transcatheter atrial septal defect closure depends on occluder size but not on patient's age. Heart 2005; 91: 219-22.
8. Anzai H, Child J, Natterson B, Krivokapich J, Fishbein MC, Chan VK, Tobis JM. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol 2004; 93: 426-31.
9. Spies C, Strasheim R, Timmermanns I, Schraeder R. Patent foramen ovale closure in patients with cryptogenic thromboembolic events using the Cardia PFO occluder. Eur Heart J 2006; 27: 365-71.
10. Brandt RR, Neumann T, Neuzner J, Rau M, Faude I, Hamm CW. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents. J Am Soc Echocardiogr 2002; 15: 1094-8.
11. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 2005; 46: 937-54.
12. Dangas G, Badimon JJ, Smith DA, Unger AH, Levine D, Shao JH, Meraj P, Fier C, Fallon JT, Ambrose JA. Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J Am Coll Cardiol 1999; 33: 1294-304.
13. Simpson IA, Lorimer AR, Walker ID, Davidson JF. Effect of Ciprofibrate on platelet aggregation and fibrinolysis in patients with hypercholesterolaemia. Thromb Haemost 1985; 54: 442-4.